[Immunosuppression and cancer: clinical aspects].
The incidence of malignancies is strikingly high in patients with primary immunodeficiency diseases. Analysis of clinical data and the types of neoplastic proliferations raise several hypothesis. Occurrence of cancers does not seem to be favored by secondary immunodeficiencies related to lymphoma or immunosuppressive therapy.
D000917:Antibody Formation; D002471:Cell Transformation, Neoplastic; D006801:Humans; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000150:complications* / Q000276:immunology; D007165:Immunosuppression Therapy; D008232:Lymphoproliferative Disorders / Q000276:immunology; D009369:Neoplasms / Q000276:immunology*
Immunosuppression et cancer: aspects cliniques.